To identify diagnostic markers and therapeutic targets by proteomics of serum and placenta for fetal growth restriction

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052694

Enrollment

Unknown

Registered

2021-11-03

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal growth restriction

Interventions

control group:none

case group:none

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women aged 20 to 35 years; 2. Singleton pregnancy; 3. Abdominal circumference (22-27 weeks of gestation) <= 3rd percentile or estimated body weight (28-30 weeks) <700g; 4. Gestational weeks < 32 weeks.

Exclusion criteria

Exclusion criteria: 1. Fetal aneuploidy or other fetal malformations, congenital infections known to cause FGR; 2. Pregnancy complications (such as pregnancy-induced hypertension, Down syndrome, gestational diabetes); 3. Maternal history of bad living habits, malnutrition, etc.

Design outcomes

Primary

Measure	Time frame
proteomics;	—

Countries

China

Contacts

Public ContactLi Jian

The Affiliated Hospital Guizhou Medical University

liamjiam@gmail.com+86 18845126348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026